SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-151903
Filing Date
2022-05-16
Accepted
2022-05-16 16:47:17
Documents
14
Period of Report
2022-05-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d338161d8k.htm   iXBRL 8-K 26302
2 EX-99.1 d338161dex991.htm EX-99.1 45112
  Complete submission text file 0001193125-22-151903.txt   241546

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA celu-20220516.xsd EX-101.SCH 4484
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celu-20220516_def.xml EX-101.DEF 13883
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE celu-20220516_lab.xml EX-101.LAB 23366
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celu-20220516_pre.xml EX-101.PRE 14845
8 EXTRACTED XBRL INSTANCE DOCUMENT d338161d8k_htm.xml XML 5880
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 609-235-1010
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 22930279
SIC: 2834 Pharmaceutical Preparations